<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Choksi Laboratories Ltd. (CHOKSILA) — Tipsheet</title>
    <link>https://tipsheet.markets/company/choksila/</link>
    <atom:link href="https://tipsheet.markets/company/choksila/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Choksi Laboratories Ltd. (CHOKSILA), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Mon, 06 Jul 2026 10:22:47 GMT</lastBuildDate>
    <item>
      <title>Choksi Labs posts 29% profit growth in FY26. Routine results.</title>
      <link>https://tipsheet.markets/choksila-choksi-labs-posts-29-profit-growth-in-fy26-routine-results-97488/</link>
      <guid isPermaLink="true">https://tipsheet.markets/choksila-choksi-labs-posts-29-profit-growth-in-fy26-routine-results-97488/</guid>
      <pubDate>Mon, 25 May 2026 16:34:17 GMT</pubDate>
      <description>Revenue grew 10% to ₹46.22 crore while net profit expanded 29% to ₹1.96 crore. The annual results were anticipated.</description>
      <content:encoded><![CDATA[<p><em>Revenue grew 10% to ₹46.22 crore while net profit expanded 29% to ₹1.96 crore. The annual results were anticipated.</em></p>
<h3>What’s new</h3><ul><li>FY26 revenue grew about 10% to ₹46.22 crore; net profit rose about 29% to ₹1.96 crore.</li><li>Q4 performance improved sequentially, with an unmodified audit opinion and no exceptional items.</li><li>The results are routine and were anticipated.</li></ul>
<h3>Why it matters</h3><p>A 29% profit increase on a 10% revenue gain points to tighter cost control at the nano-cap. But the results were expected and contain no new information. They do not change the investment case.</p>
<h3>What we’re watching</h3><ul><li>Whether the 29% profit growth rate can be sustained into FY27.</li><li>Any management commentary on the drivers of the profit expansion.</li><li>The next quarterly update for signs of acceleration.</li></ul>
<h3>The full read</h3><p>Choksi Laboratories' FY26 results are exactly what a steady nano-cap looks like. Revenue grew <strong>10%</strong> to <strong>₹46.22 crore</strong>. Profit grew faster, climbing <strong>29%</strong> to <strong>₹1.96 crore</strong>. The margin expanded. Q4 was better than Q3. The audit is clean. Nothing broke. For a company of this size, that is the point. These numbers confirm the existing trajectory. They do not alter it. The <strong>29%</strong> profit growth is solid. The open question is whether it is sustainable, and the filing offers no new clues.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=526546&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=CHOKSILA">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>